Estrella Immunopharma Inc (ESLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,450 | -7,649 | -2,104 | N/A | -7,797 |
| Accounts payable and accrued liabilities | 1 | 4 | 10 | N/A | -72 |
| Other Working Capital | 10,305 | 6,450 | 1,479 | N/A | 1,054 |
| Other Operating Activity | 536 | 315 | 150 | 0 | 72 |
| Operating Cash Flow | $-1,608 | $-881 | $-466 | $N/A | $-6,744 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,400 | 1,350 | N/A | N/A | N/A |
| Common Stock Repurchased | -30 | -30 | -30 | N/A | -505 |
| Other Financing Activity | -53 | -40 | 0 | 0 | 0 |
| Financing Cash Flow | $2,318 | $1,281 | $-30 | $N/A | $-505 |
| Beginning Cash Position | 917 | 917 | 917 | N/A | 9,046 |
| End Cash Position | 1,627 | 1,317 | 422 | N/A | 1,798 |
| Net Cash Flow | $710 | $400 | $-495 | $N/A | $-7,249 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,608 | -881 | -466 | N/A | -6,744 |
| Free Cash Flow | -1,608 | -881 | -466 | 0 | -6,744 |